In the present study, cell culture experiments combined with proteomic analyses (mass spectrometry, co-immunoprecipitation, Western blotting) were applied to better characterize a role of PHLDA1 protein in the response of IMR-32 human neuroblastoma cells to chimeric ch14.18/CHO antibody. The gene discussed is PHLDA1; the disease is neuroblastoma.